SAREUM HOLDINGS PLC
Clinical-stage company developing kinase inhibitors for autoimmune diseases and cancer.
SAR | IL
Overview
Corporate Details
- ISIN(s):
- GB00BMC3RJ87
- LEI:
- 213800PKERN2DY8FFM72
- Country:
- United Kingdom
- Address:
- UNIT 2A, CB22 3FX CAMBRIDGE
- Website:
- https://www.sareum.com/
- Sector:
- Manufacturing
Description
Sareum Holdings PLC is a clinical-stage small molecule company that discovers and develops next-generation kinase inhibitors for the treatment of autoimmune diseases and cancer. The company's research is primarily focused on the TYK/JAK kinase cell signalling family, with a specific emphasis on developing dual inhibitors of TYK2 and JAK1. This approach is pursued for its potential to offer superior efficacy compared to agents that target only one of these kinases. Its development pipeline includes SDC-1801, a potential oral therapy for autoimmune diseases, as well as other programs targeting cancer and viral infections.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-02-28 15:04 |
Sierra Oncology has reported its 2018 Results
|
English | 17.1 KB | ||
| 2019-02-28 09:14 |
New SRA737 preclin data to be presented at AACR
|
English | 18.5 KB | ||
| 2019-01-23 14:38 |
Sierra Oncology to present SRA737 at DDR Tx Summit
|
English | 17.7 KB | ||
| 2018-12-18 13:35 |
Results of AGM
|
English | 16.3 KB | ||
| 2018-12-18 08:00 |
AGM Statement
|
English | 21.4 KB | ||
| 2018-11-30 12:17 |
Amendment to Preclinical Efficacy Announcement
|
English | 18.1 KB | ||
| 2018-11-30 08:45 |
Preclinical Efficacy for Immunotherapy Combination
|
English | 17.1 KB | ||
| 2018-11-15 11:24 |
Preclinical Data for SRA737 in Ovarian Cancer
|
English | 18.5 KB | ||
| 2018-11-14 08:00 |
AGM NOTICE
|
English | 15.9 KB | ||
| 2018-11-13 08:00 |
Directorate Change
|
English | 19.5 KB | ||
| 2018-11-08 13:28 |
Sierra Oncology Q3 2018 Results
|
English | 16.6 KB | ||
| 2018-10-26 09:00 |
Completion of Placing
|
English | 17.8 KB | ||
| 2018-10-01 09:00 |
FINAL RESULTS FOR THE YEAR ENDED 30 JUNE 2018
|
English | 196.1 KB | ||
| 2018-09-27 15:03 |
Notice of Results
|
English | 14.5 KB | ||
| 2018-09-26 09:00 |
TYK2/JAK1 selected for certain cancers
|
English | 17.2 KB |
Automate Your Workflow. Get a real-time feed of all SAREUM HOLDINGS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SAREUM HOLDINGS PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SAREUM HOLDINGS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
